Larry Todd Edwards is CCO & VP at Arcutis Biotherapeutics, Inc. (ARQT). They have made 9 open-market trades across 1 company since 2024, most recently 2026-08-24.
CIK 0001994805
1 open-market purchase totalling $8K since 2024, against 8 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ORKA | 100,000 | $10.1M |
| ARQT | 175,178 | $6.0M |
| Total | $16.1M |
Shares reported on the most recent Form 4, priced at the 2026-08-25 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ARQT | SELL | 2026-03-02 | 2026-03-03 | $25.18 | $93K | -3.0% | +0.8% | -8.3% |
| ARQT | SELL | 2026-02-02 | 2026-02-04 | $25.50 | $52K | +1.6% | -8.3% | -10.5% |
| ARQT | SELL | 2025-11-06 | 2025-11-10 | $25.16 | $1.5M | +15.7% | +26.0% | +13.8% |
| ARQT | SELL | 2025-10-02 | 2025-10-06 | $20.02 | $174K | +5.4% | +22.9% | +52.2% |
| ARQT | SELL | 2025-05-19 | 2025-05-20 | $14.07 | $210K | -5.8% | -3.4% | +17.0% |
| ARQT | SELL | 2025-02-03 | 2025-02-04 | $12.70 | $28K | -2.7% | +10.4% | +17.4% |
| ARQT | BUY | 2024-11-30 | 2024-12-03 | $7.11 | $8K | +1.6% | +16.6% | +2.7% |
| ARQT | SELL | 2024-10-02 | 2024-10-03 | $10.01 | $37K | -8.3% | -14.5% | +42.7% |
| ARQT | SELL | 2024-05-17 | 2024-05-20 | $8.98 | $137K | -9.6% | -10.5% | -6.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.